MECP2 and epilepsy: In a study by Colic et al., 2016 of a Mecp2-deficient model of Rett syndrome and epilepsy, 2–5 Hz delta rhythm was found as a biomarker in the prediction of antiepileptic drug treatment (Colic et al., 2016).